Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum

Diabetic Medicine

Volumn 22, Issue 4, 2005, Pages 434-439

  Loukovaara, Mikko ^a   Leinonen, P ^a   Teramo, K ^a   Nurminen, E ^a   Andersson, S ^b   Rutanen, E M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Fetus; Gestational diabetes; Insulin like growth factor binding protein 1; Phosphoisoform; Type 1 diabetes

Indexed keywords

INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; BINDING AFFINITY; BIRTH WEIGHT; CONTROLLED STUDY; CORD SERUM; ENZYME IMMUNOASSAY; FEMALE; FETUS; FETUS BLOOD; FETUS GROWTH; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ADULT; BIRTH WEIGHT; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; FETAL BLOOD; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PHOSPHORYLATION; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; PROTEIN ISOFORMS;

EID: 17144424999     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01430.x     Document Type: Article

References (29)

1. Rosenfeld RG. Insulin-like growth factors and the basis of growth. N Engl J Med 2003; 349: 2184-2186.
2. Kim H-S, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997; 94: 12981-12986.
3. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 18: 801-831.
4. Drop SLS, Kortleve DJ, Guyda HJ, Bosner BI. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal and adult sera. J Clin Endocrinol Metab 1984; 59: 908-915.
5. Wang HS, Chard T. Chromatographic characterisation of insulin-like growth factor-binding proteins in human pregnancy serum. J Endocrinol 1992; 133: 149-159.
6. Holly JMP, Biddlecombe RA, Dunger DB, Edge JA, Amiel SA, Howell R et al. Circadian variation of GH-independent IGF binding protein in diabetes mellitus and its relationship to insulin: a new role for insulin? Clin Endocrinol 1988; 29: 667-675.
7. Suikkari A-M, Koivisto VA, Rutanen E-M, Yki-Järvinen H, Karonen S-L, Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266-272.
8. Westwood M, Gibson JM, White A. Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma. Endocrinology 1997; 138: 1130-1136.
9. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994; 79: 1735-1741.
10. Jones JI, D'Ercole J, Camacho-Hubner C, Clemmons DR. Phosphorylation of IGFBP-1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 1991; 88: 7481-7485.
11. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993; 169: 89-97.
12. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80: 1548-1555.
13. Schwartz R, Teramo KA. Effect of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000; 24: 120-135.
14. Culler FL, Tung RF, Jansons RA, Mosier HD. Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins. J Pediatr Endocrinol Metab 1996; 9: 21-29.
15. Liu Y-J, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K et al. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1-2 and -3) in diabetic pregnancy: relationship to macrosomia. Endocr J 1996; 43: 221-231.
16. Hyvönen K. Gestaatiodiabeteksen esiintyvyys ja seulonta (Incidence and Screening of Gestational Diabetes). Publications of the University of Kuopio, Finland. Original reports 6/1991. Kuopio, Finland: University of Kuopio, 1991.
17. Teramo KA, Widness JA, Clemons GK, Voutilainen PE, McKinlay S, Schwartz R. Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 1987; 69: 710-716.
18. Pihkala J, Hakala T, Voutilainen P, Raivio K. Uudet suomalaiset sikiön kasvukäyrät (Characteristic of recent fetal growth curves in Finland). Duodecim 1989; 105: 1540-1546.
19. Rutanen E-M, Kärkkäinen T, Lundqvist C, Pekonen F, Ritvos O, Tanner P et al. Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein. Biochem Biophys Res Commun 1998; 152: 208-215.
20. Rutanen E-M, Kärkkäinen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1996; 253: 91-101.
21. Nuutila M, Hiilesmaa V, Kärkkäinen T, Ylikorkala O, Rutanen E-M. Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 1999; 94: 243-249.
22. Westwood M. Role of insulin-like growth factor binding protein 1 in human pregnancy. Rev Reprod 1999; 4: 160-167.
23. Pannier EM, Irwin JC, Giudice LC. Insulin-like growth factor binding proteins (IGFBPs) in the human fetus: tissue-specific protein secretion, immunologic characterization, and gene expression. Am J Obstet Gynecol 1994; 171: 746-752.
24. Drop SL, Valiquette G, Guyda HJ, Corvol MT, Posner BI. Partial purification and characterization of a binding protein for insulin-like activity in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinol (Copenh) 1979; 90: 505-518.
25. Rutanen E-M, Menabawey M, Isaka K, Bohn H, Chard T, Grudzinskas JG. Synthesis of placental protein 12 by decidua from early pregnancy. J Clin Endocrinol Metab 1986; 63: 675-679.
26. Zhou J, Bondy C. Insulin-like growth factor II and its binding proteins in placental development. Endocrinology 1992; 131: 1230-1240.
27. Iwashita M, Sakai K, Kudo Y, Takeda Y. Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 1998; 8: 487-493.
28. Gibson JM, Westwood M, Lauszus FF, Klebe JG, Flyvbjerg A, White A. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects. Diabetes 1999; 48: 321-326.
29. Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 1998; 95: 10188-10193.